Toll-Like Receptor 4: A Novel Target to Tackle Drug Addiction?

Handb Exp Pharmacol. 2022:276:275-290. doi: 10.1007/164_2022_586.

Abstract

Drug addiction is a chronic brain disease characterized by compulsive drug-seeking and drug-taking behaviors despite the major negative consequences. Current well-established neuronal underpinnings of drug addiction have promoted the substantial progress in understanding this disorder. However, non-neuronal mechanisms of drug addiction have long been underestimated. Fortunately, increased evidence indicates that neuroimmune system, especially Toll-like receptor 4 (TLR4) signaling, plays an important role in the different stages of drug addiction. Drugs like opioids, psychostimulants, and alcohol activate TLR4 signaling and enhance the proinflammatory response, which is associated with drug reward-related behaviors. While extensive studies have shown that inhibition of TLR4 attenuated drug-related responses, there are conflicting findings implicating that TLR4 signaling may not be essential to drug addiction. In this chapter, preclinical and clinical studies will be discussed to further evaluate whether TLR4-based neuroimmune pharmacotherapy can be used to treat drug addiction. Furthermore, the possible mechanisms underlying the effects of TLR4 inhibition in modulating drug-related behaviors will also be discussed.

Keywords: Alcohol; Drug addiction; Non-neuronal mechanisms; Opioid; Psychostimulants; Toll-like receptor 4.

MeSH terms

  • Analgesics, Opioid / pharmacology
  • Drug-Seeking Behavior* / drug effects
  • Ethanol / pharmacology
  • Humans
  • Signal Transduction
  • Substance-Related Disorders* / drug therapy
  • Substance-Related Disorders* / genetics
  • Toll-Like Receptor 4* / antagonists & inhibitors

Substances

  • Analgesics, Opioid
  • Toll-Like Receptor 4
  • Ethanol